Contact
searchSearch
HMP Global

Transplant

Featured Article

News
Immunosuppressants After Solid Organ Transplant Carry Nutritional Implications
07/17/2024
Jolynn Tumolo
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid...
07/17/2024
Pharmacy Learning Network
News
Immunosuppressant Recalled
05/30/2024
Jolynn Tumolo
Dr Reddy’s Laboratories Inc. is recalling 1176 bottles of sirolimus tablets for failing to meet impurities/degradation specifications.
Dr Reddy’s Laboratories Inc. is recalling 1176 bottles of sirolimus tablets for failing to meet impurities/degradation specifications.
Dr Reddy’s Laboratories Inc. is...
05/30/2024
Pharmacy Learning Network
News
Pharmacies Are Turning Away Immunocompromised Patients Seeking Fourth COVID-19 Shot
01/26/2022
Liz Szabo
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from...
01/26/2022
Pharmacy Learning Network
News
Alemtuzumab-Based Induction Promising for Kidney Transplant
08/17/2014
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard...
08/17/2014
Pharmacy Learning Network

News
Immunosuppressants After Solid Organ Transplant Carry Nutritional Implications
07/17/2024
Jolynn Tumolo
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid...
07/17/2024
Pharmacy Learning Network
News
Immunosuppressant Recalled
05/30/2024
Jolynn Tumolo
Dr Reddy’s Laboratories Inc. is recalling 1176 bottles of sirolimus tablets for failing to meet impurities/degradation specifications.
Dr Reddy’s Laboratories Inc. is recalling 1176 bottles of sirolimus tablets for failing to meet impurities/degradation specifications.
Dr Reddy’s Laboratories Inc. is...
05/30/2024
Pharmacy Learning Network
News
Pharmacies Are Turning Away Immunocompromised Patients Seeking Fourth COVID-19 Shot
01/26/2022
Liz Szabo
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from...
01/26/2022
Pharmacy Learning Network
News
Alemtuzumab-Based Induction Promising for Kidney Transplant
08/17/2014
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard...
08/17/2014
Pharmacy Learning Network
News
Povidone and Proparacaine Ophthalmic Solution Recalled Due to Drug Subpotency
09/17/2026
Rebecca Amrick
Povidone iodine and proparacaine hydrochloride ophthalmic solution is under a voluntary Class III recall due to drug subpotency, affecting 772 bottles.
Povidone iodine and proparacaine hydrochloride ophthalmic solution is under a voluntary Class III recall due to drug subpotency, affecting 772 bottles.
Povidone iodine and proparacaine...
09/17/2026
Pharmacy Learning Network
News
Fluphenazine Hydrochloride Tablets Recalled Due to Failed Impurities Specifications
09/17/2026
Rebecca Amrick
A voluntary Class III recall has been issued for fluphenazine hydrochloride tablets after the product failed to meet impurities specifications, a discrepancy that affects 403 200 tablets.
A voluntary Class III recall has been issued for fluphenazine hydrochloride tablets after the product failed to meet impurities specifications, a discrepancy that affects 403 200 tablets.
A voluntary Class III recall has...
09/17/2026
Pharmacy Learning Network
News
Dextrose Injection Recalled Due to the Presence of Stainless Steel Particles
09/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for dextrose injection due to the presence of stainless steel particles in the product, affecting 606 bags.
The US Food and Drug Administration (FDA) has issued a Class I recall for dextrose injection due to the presence of stainless steel particles in the product, affecting 606 bags.
The US Food and Drug...
09/17/2026
Pharmacy Learning Network
PharmLaw
Dompé to Pay $32 Million Over Patient Assistance Foundation Kickback Allegations
09/16/2026
Hannah Musick
Dompé U.S. has agreed to pay $32 million to resolve allegations involving Medicare copay assistance for Oxervate, highlighting Anti-Kickback Statute compliance risks associated with manufacturer-funded patient assistance programs and the...
Dompé U.S. has agreed to pay $32 million to resolve allegations involving Medicare copay assistance for Oxervate, highlighting Anti-Kickback Statute compliance risks associated with manufacturer-funded patient assistance programs and the...
Dompé U.S. has agreed to pay $32...
09/16/2026
Pharmacy Learning Network
News
Topiramate Capsules Recalled Due to Failed Dissolution Specifications
09/10/2026
Rebecca Amrick
Trokendi (topiramate) extended-release capsules are under a voluntary Class III recall due to failed dissolution specifications, affecting 11 304 bottles.
Trokendi (topiramate) extended-release capsules are under a voluntary Class III recall due to failed dissolution specifications, affecting 11 304 bottles.
Trokendi (topiramate)...
09/10/2026
Pharmacy Learning Network
News
Trazodone Hydrochloride Tablets Recalled Due to the Presence of Foreign Tablets
09/10/2026
Rebecca Amrick
A voluntary Class II recall has been issued for trazodone hydrochloride tablets after the firm discovered foreign tablets in the product, a discrepancy that affects 175 392 bottles.
A voluntary Class II recall has been issued for trazodone hydrochloride tablets after the firm discovered foreign tablets in the product, a discrepancy that affects 175 392 bottles.
A voluntary Class II recall has...
09/10/2026
Pharmacy Learning Network
News
Famotidine Injection Recalled Due to CGMP Deviations
09/10/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for famotidine injection due to Current Good Manufacturing Practice (CGMP) deviations.
The US Food and Drug Administration (FDA) has issued a Class II recall for famotidine injection due to Current Good Manufacturing Practice (CGMP) deviations.
The US Food and Drug...
09/10/2026
Pharmacy Learning Network
PharmLaw
Florida Alleges Express Scripts, Prime Therapeutics Engaged in PBM Reimbursement Price-Fixing
09/09/2026
Hannah Musick
Florida has sued Express Scripts and Prime Therapeutics over allegations that the pharmacy benefit managers (PBMs) unlawfully coordinated pharmacy reimbursement rates, raising new antitrust and compliance questions surrounding PBM contracting...
Florida has sued Express Scripts and Prime Therapeutics over allegations that the pharmacy benefit managers (PBMs) unlawfully coordinated pharmacy reimbursement rates, raising new antitrust and compliance questions surrounding PBM contracting...
Florida has sued Express Scripts...
09/09/2026
Pharmacy Learning Network
News
Repository Corticotropin Injection Recalled Due to the Presence of Particulate Matter
09/03/2026
Rebecca Amrick
Acthar Gel (repository corticotropin) injection is under a voluntary Class II recall due to the presence of particulate matter, affecting 12 367 vials.
Acthar Gel (repository corticotropin) injection is under a voluntary Class II recall due to the presence of particulate matter, affecting 12 367 vials.
Acthar Gel (repository...
09/03/2026
Pharmacy Learning Network
News
Clobetasol Propionate Cream Recalled Due to Failed Content Uniformity Specifications
09/03/2026
Rebecca Amrick
A voluntary Class II recall has been issued for clobetasol propionate cream after the product failed to meet content uniformity specifications.
A voluntary Class II recall has been issued for clobetasol propionate cream after the product failed to meet content uniformity specifications.
A voluntary Class II recall has...
09/03/2026
Pharmacy Learning Network

What's New?

News
Immunosuppressants After Solid Organ Transplant Carry Nutritional Implications
07/17/2024
Jolynn Tumolo
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid...
07/17/2024
Pharmacy Learning Network
News
Immunosuppressant Recalled
05/30/2024
Jolynn Tumolo
Dr Reddy’s Laboratories Inc. is recalling 1176 bottles of sirolimus tablets for failing to meet impurities/degradation specifications.
Dr Reddy’s Laboratories Inc. is recalling 1176 bottles of sirolimus tablets for failing to meet impurities/degradation specifications.
Dr Reddy’s Laboratories Inc. is...
05/30/2024
Pharmacy Learning Network
News
Pharmacies Are Turning Away Immunocompromised Patients Seeking Fourth COVID-19 Shot
01/26/2022
Liz Szabo
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from...
01/26/2022
Pharmacy Learning Network
News
Alemtuzumab-Based Induction Promising for Kidney Transplant
08/17/2014
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard...
08/17/2014
Pharmacy Learning Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use